Title: Overactive Chemoreceptor Cells: A Hidden Culprit Behind Diabetes and Hypertension
Article:
In the shadows of type 2 diabetes and hypertension lies a subtler but equally perilous factor: overactive chemoreceptor cells. Located near the carotid artery, these cells have been identified as a major contributor to the onset and exacerbation of cardiovascular and metabolic diseases. Research from the University of Missouri has revealed that when these cells become hyperactive, health risks escalate significantly. While oxygen therapy has helped reduce their activity, the effect wasn’t sufficient to improve metabolic functions. A recent study raises more questions about the role of these cells and the therapies that could finally offer a real solution.
The Enigmatic Link: Chemoreceptor Cells and Cardiovascular-Metabolic Disorders
At the heart of the study are specific groups of chemoreceptor cells situated near the carotid artery in the neck. These cells play a crucial role in detecting oxygen levels in the body. When they become overactive, they are strongly linked to increased risks of cardiovascular conditions, such as hypertension, and metabolic disorders, including type 2 diabetes. Researchers aim to determine if targeting these cells could offer a potential therapy for these conditions.
The Oxygen Therapy Conundrum
The study, led by Jacqueline Limberg, an Associate Professor of Nutrition and Exercise Physiology, investigates whether altering oxygen levels could influence the activity of these chemoreceptor cells. Earlier studies on mice showed that eliminating overactive chemoreceptors could improve symptoms related to hypertension and elevated blood sugar levels. Limberg and her team hypothesized that high doses of oxygen could help "switch off" these cells, potentially improving patient outcomes.
The study involved two groups of participants: 17 individuals with type 2 diabetes and 20 non-diabetics serving as the control group. The results showed that peripheral chemoreceptors in diabetics were overactive, with the highest activity levels corresponding to the highest blood sugar values. Participants were exposed to hypoxia – a state where oxygen levels are increased. Post-exposure, chemoreceptor activity decreased, and heart rate, blood pressure, and respiratory rate significantly dropped. However, the effect did not differ significantly between the two groups. Notably, the oxygen therapy had no impact on glucose tolerance or insulin sensitivity in either group.
While the study provided valuable insights into how chemoreceptor activity affects cardiovascular and metabolic health, it also showed that a single hypoxia session does not immediately improve these functions. As explained by Camila Manrique-Acevedo, co-author and Professor of Medicine, "now that we understand that one hypoxia session doesn’t bring immediate benefits, we can focus on other therapies that might be more efficient for type 2 diabetes patients," according to SciTechDaily.
The findings suggest that further research is needed to fully understand the relationship between chemoreceptor activity and diabetes, and to identify more effective treatments to improve cardiovascular and metabolic health in individuals with this chronic condition.
Stay updated with the latest news. Follow DCMedical and on Google News.
Did this article help you?
Follow DCMedical on Facebook and Instagram for more useful content on health, disease prevention, first aid tips, and useful advice from doctors and patients.*
Keep reading